Education
About Us
Working with TipRanks
Follow Us
S2Medical AB Class B (DE:S21)
:S21
Total Valuation
S2Medical AB Class B has a market cap or net worth of €1.46M. The enterprise value is €32.37M.
Market Cap€1.46M
Enterprise Value€32.37M
Share Statistics
S2Medical AB Class B has 836,139,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding836,139,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
S2Medical AB Class B’s return on equity (ROE) is 0.49 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.49
Return on Assets (ROA)0.32
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.49
Revenue Per Employee876.82K
Profits Per Employee339.71K
Employee Count17
Asset Turnover0.82
Inventory Turnover1.89
Valuation Ratios
The current PE Ratio of S2Medical AB Class B is 1.02. S2Medical AB Class B’s PEG ratio is -0.04.
PE Ratio1.02
PS Ratio0.00
PB Ratio5.11
Price to Fair Value0.50
Price to FCF-1.20
Price to Operating Cash Flow-1.28
PEG Ratio-0.04
Income Statement
In the last 12 months, S2Medical AB Class B had revenue of 14.91M and earned 5.77M in profits. Earnings per share was 0.01.
Revenue14.91M
Gross Profit14.14M
Operating Income5.79M
Pretax Income5.77M
Net Income5.77M
EBITDA6.82M
Earnings Per Share (EPS)0.01
Cash Flow
In the last 12 months, operating cash flow was 14.45M and capital expenditures -1.14M, giving a free cash flow of 13.31M billion.
Operating Cash Flow14.45M
Free Cash Flow13.31M
Free Cash Flow per Share0.02
Dividends & Yields
S2Medical AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta10.61
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)867.00
Important Dates
S2Medical AB Class B upcoming earnings date is Aug 22, 2025, TBA Not Confirmed.
Last Earnings DateNov 15, 2024
Next Earnings DateAug 22, 2025
Ex-Dividend Date―
Financial Position
S2Medical AB Class B as a current ratio of 0.90, with Debt / Equity ratio of 0.00%
Current Ratio0.90
Quick Ratio0.84
Debt to Market Cap0.00
Net Debt to EBITDA-0.15
Interest Coverage Ratio289.55
Taxes
In the past 12 months, S2Medical AB Class B has paid 5.77M in taxes.
Income Tax5.77M
Effective Tax Rate1.00
Enterprise Valuation
S2Medical AB Class B EV to EBITDA ratio is 0.71, with an EV/FCF ratio of 1.96.
EV to Sales0.33
EV to EBITDA0.71
EV to Free Cash Flow1.96
EV to Operating Cash Flow1.56
Balance Sheet
S2Medical AB Class B has €1.37M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€1.37M billion.
Cash & Marketable Securities€1.37M
Total Debtkr0.00
Net Cash-€1.37M
Net Cash Per Share>-€0.01
Tangible Book Value Per Share>-€0.01
Margins
Gross margin is 110.60%, with operating margin of 38.85%, and net profit margin of 38.72%.
Gross Margin110.60%
Operating Margin38.85%
Pretax Margin38.72%
Net Profit Margin38.72%
EBITDA Margin45.77%
EBIT Margin38.85%
Analyst Forecast
The average price target for S2Medical AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―